Regulatory Factsheet
Scientific advice US-FDA
The FDA has four meeting types, type A (help a stalled product development program), type B (pre-IND meeting, pre- NDA/BLA meeting, meeting to discuss overall development for products granted breakthrough therapy designation), end of phase type B (certain end of phase 1 meetings, end of phase 2 and pre phase 3 meetings), and type C (any meeting regarding development and review of a product that isn’t any of the other types). For more information on our 2-page factsheet on Scientific Advice (US-FDA), download below.
